Stay updated on INTRUST: Urelumab/Nivolumab Combo Clinical Trial

Sign up to get notified when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial page is accessible again, showing the study’s treatment plan, eligibility criteria, locations, outcomes, and related publications in place of an error page.
    Difference
    69%
    Check dated 2026-11-09T23:46:16.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T23:28:18.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH website updates and explains the transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T23:28:59.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T23:54:50.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T05:46:18.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the full study record with a minimal message. As a result, core trial details and history sections are no longer visible, blocking access to the study information.
    Difference
    20%
    Check dated 2026-09-21T23:53:51.000Z thumbnail image

Stay in the know with updates to INTRUST: Urelumab/Nivolumab Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INTRUST: Urelumab/Nivolumab Combo Clinical Trial page.